Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Other Non-Current Assets (2016 - 2025)

Palisade Bio has reported Other Non-Current Assets over the past 16 years, most recently at $68000.0 for Q4 2025.

  • Quarterly Other Non-Current Assets rose 161.54% to $68000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $68000.0 through Dec 2025, up 161.54% year-over-year, with the annual reading at $68000.0 for FY2025, 161.54% up from the prior year.
  • Other Non-Current Assets was $68000.0 for Q4 2025 at Palisade Bio, down from $171000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $868000.0 in Q4 2021 and troughed at $12000.0 in Q4 2023.
  • The 5-year median for Other Non-Current Assets is $26000.0 (2021), against an average of $200563.3.
  • Year-over-year, Other Non-Current Assets skyrocketed 3238.46% in 2021 and then tumbled 97.26% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $868000.0 in 2021, then crashed by 97.0% to $26000.0 in 2022, then tumbled by 53.85% to $12000.0 in 2023, then surged by 116.67% to $26000.0 in 2024, then surged by 161.54% to $68000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Other Non-Current Assets are $68000.0 (Q4 2025), $171000.0 (Q2 2025), and $26000.0 (Q1 2025).